Select Page

How does COVID-19 affect the HCPs' relationships with patients and with the pharmaceutical industry? The results of the 2nd phase of our syndicated Covid-19 impact study are available for the French market, and a third wave was launched in Spring 2021

Understand the past and expected evolutions of the remote mode for patient consultations, medical and sales reps promotionor attending medical conferences or local meetings, all analyzed among various specialties: General Practitioners, Oncologists, Onco-hematologists, Hematologists, Psychiatrists, Urologists, Dermatologists, Cardiologists, Gastroenterologists, Pneumologists, Rheumatologists.

Do you want to know more about this study?

The results of both phases are available from a large panel of specialties interviewed in France in spring and fall 2020 (General practitioners, Oncologists, Onco-hematologistsHematologists, Psychiatrists, Urologists, Dermatologists, Cardiologists, Gastroenterologists, Pneumologists, Rheumatologists, ...). A third phase is launched in May 2021.

Are you interested in deploying this study in other markets than France? Contact us by filling our contact form. 

Would you like to obtain the results or request more information on the COVID-19 Impact syndicated study? Fill out the form below and we will contact you as soon as possible.